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cancer, lung cancer and prostate cancer. 3, 4 However, most cervical cancers are not sensitive to currently available molecular targeted therapies. 5 Therefore, further enhancing our understanding of molecular mechanisms underlying the initiation and progression of cervical cancer is beneficial for developing more effective treatments for cervical cancer. 6 Transcriptome sequencings have found many deregulated non-coding RNAs in cancers. 7, 8 Concurrently, increasingly reports have shown the important roles of non-coding RNAs in multiple cancers. [9] [10] [11] Among these non-coding RNAs, microRNAs and long non-coding RNAs are two main classes. microRNAs (miRNAs) are a class of short RNAs with a length of [21] [22] [23] [24] [25] nucleotides. [12] [13] [14] [15] [16] Long non-coding RNAs (lncRNAs) are a class of long RNAs with lengths of more than 200 nucleotides and limited protein coding potential. [17] [18] [19] [20] miRNAs are well known to induce translation repression and/or degradation of their target messenger RNAs (mRNAs) via base pairing at partially or fully complementary sites. [21] [22] [23] [24] The function manners of lncRNAs are complex and various. [25] [26] [27] [28] One of the action mechanisms of lncRNAs is to physically bind and sequester miRNAs and relieve the repressive roles of miRNAs on their genuine target mRNAs. [29] [30] [31] These lncRNAs are also known as competitive endogenous RNAs (ceRNAs). 32, 33 In our previous study, we have identified that miR-214 is down-regulated in human cervical cancer and significantly inhibits cervical cancer growth. 34 Other reports also showed the tumour suppressive roles of miR-214 in cervical cancer via modulating cell survival, cell migration, cell invasion, drug sensitive and so on. [35] [36] [37] [38] [39] Except for cervical cancer, miR-214 was also reported by different authors to act as tumour suppressor in multiple cancers, including colorectal cancer, oesophageal squamous cell carcinoma, breast cancer, papillary thyroid carcinoma and so on. 37, [40] [41] [42] Because several lncRNAs are revealed to bind and sequester miRNAs and block the roles of miRNAs, we hypothesized that there are lncRNAs, which bind and sequester miR-214 and further exert oncogenic roles in cervical cancer.
In this study, we performed an unbiased screen to search the lncRNAs which could bind miR-214 and finally identify lncRNA LINC01535 as a ceRNA for miR-214. We investigated the expression and roles of LINC01535, and resolved in detail, the mechanisms of action of LINC01535 in cervical cancer.
| MATERIAL S AND ME THODS

| Cell culture
Human cervical cancer cell lines HeLa, SiHa and CaSki were obtained from the American Type Culture Collection (Manassas, VA,
USA). HeLa and SiHa cells were maintained in Eagle's Minimum
Essential Medium (MEM) (Invitrogen, Carlsbad, CA, USA). CaSki cells were maintained in RPMI-1640 Medium (Invitrogen). All the cells were cultured in the medium supplemented with 10% foetal bovine serum (Invitrogen) at 37°C with 5% CO 2 . 
| Plasmids construction
| Isolation of cytoplasmic and nuclear RNA
Cytoplasmic and nuclear RNA from HeLa cells was isolated using the Cytoplasmic & Nuclear RNA Purification Kit (Norgen, Belmont, CA, USA) following the manufacturer's instruction. The gene expression for specific genes was measured using qRT-PCR.
| RNA isolation and quantitative real-time polymerase chain reaction (qRT-PCR)
RNA was extracted using the TRIzol Reagent (Invitrogen) following the manufacturer's instruction. Next, reverse transcription was carried out using the extracted RNA and PrimeScript™ II 1st 
| Western blot
| Stable cell lines construction
To stably overexpress LINC01535 in HeLa and SiHa cells, pcDNA- Seventy-two hours after transfection, the cells were selected with puromycin for 4 weeks.
| Cell viability assay and Ethynyl deoxyuridine (EdU) staining assay
Cell growth ability was evaluated by Glo cell viability assay and Ethynyl deoxyuridine (EdU) staining assay. For Glo cell viability assay, 3000 indicated cervical cancer cells were seeded into 96-well plates per well. After culture for indicated time, cell viabilities were measured using the CellTiter-Glo ® Luminescent Cell Viability Assay (Promega) in accordance with the manufacturer's protocol.
EdU staining was performed using the EdU kit (RiboBio, Guangzhou, China) in accordance with the manufacturer's protocol. The percentage of EdU positive cells was evaluated using Zeiss Photomicroscope (Carl Zeiss, Oberkochen, Germany) and counted dependent on at least five random fields.
| Transwell migration and invasion assays
Cell migration and invasion ability was evaluated by transwell migration and invasion assays. Forty thousand indicated cervical cancer cells re-suspended in serum-free medium were plated into the 24-well transwell chambers (Millipore) per well. For invasion assay, the transwell chambers were pre-coated with Matrigel (BD Biosciences, San Jose, CA, USA). Complete medium containing 10% foetal bovine serum was added into the lower chamber. After incubation for 48 hours, the non-migratory and non-invasive cells at upper chambers were removed using cotton-tipped swabs. The migratory and invasive cells at the lower surfaces of chambers were fixed using methanol and stained using 0.1% crystal violet solution. The counting of the migratory and invasive cells was performed using Zeiss Photomicroscope dependent on at least five random fields.
| Xenograft assay in mice
Five-six-week-old female BALB/c-nu/nu nude mice were purchased from SLRC Laboratory Animal Center (Shanghai, China) and bred in the pathogen-free condition. 
| Clinical specimens
| Immunohistochemistry (IHC) staining
Quantification of EZH2 expression in cervical cancer tissues was performed using immunohistochemistry (IHC) staining as previously described with an EZH2 specific antibody (Cell Signaling Technology (Table S1 ). Notably, one of these predicted lncRNAs, LINC01535 has three consecutive miR-214 binding sites in a span of 68 nucleotides ( Figure 1A ), which indicates strong possibility of miRNAlncRNA binding. Next, the 3' 630 nucleotides of LINC01535 containing the predicted miR-214 binding sites were cloned into luciferase reporter pmirGLO. Dual luciferase reporter assays displayed that enhanced expression of miR-214 significantly repressed the luciferase activity of constructed reporter but not empty reporter ( Figure 1B) . Reciprocally, inhibition of miR-214 significantly increased the luciferase activity of constructed reporter but not empty reporter ( Figure 1C ). Subcellular distribution of LINC01535 in cervical cancer cells was detected. As displayed in Figure 1D , LINC01535 was mainly located in cytoplasm, which supports the potential binding between LINC01535 and miRNAs. To validate the direct binding between LINC01535 and miR-214, affinity pull-down of endogenous miR-214 by in vitro transcribed biotinylated LINC01535 was carried out. As displayed in Figure 1E , miR-214 was specifically enriched by LINC01535. Therefore, these data demonstrated that LINC01535 physically binds miR-214.
| LINC01535 represses the miR-214/EZH2 regulatory loop
Many previous reports including ours have identified EZH2 as a critical target of miR-214 in various cancers including cervical cancer.
34,44
Thus, we further investigated the effects of LINC01535 on EZH2. Results are displayed as the relative ratio of Firefly luciferase activity to Renilla luciferase activity. D, The levels of LINC01535 in cytoplasmic or nuclear RNAs purified from Huh7 cells. U6 and GAPDH serve as nuclear and cytoplasmic control, respectively. E, HeLa cell lysates were incubated with biotin-labeled LINC01535; after pull-down, miRNAs was extracted and detected by qRT-PCR. Results are shown as mean ± SD of three independent experiments. **P < 0.01, ***P < 0.001, ns, not significant, by Student's t test suggested that inhibition of LINC01535 suppresses cervical cancer cell growth, migration and invasion.
| Activation of the miR-214/EZH2 regulatory loop reverses the roles of LINC01535 on cervical cancer cell growth, migration and invasion
To determine whether the oncogenic roles of LINC01535 in cervical cancer are dependent on the repression of miR-214/EZH2 regulatory loop, we stably overexpressed miR-214 or stably silenced EZH2 in LINC01535 stably overexpressed HeLa cells ( Figure 5A , 5B). The results further showed that although LINC01535 down-regulated miR-214 and up-regulated EZH2, neither overexpression of miR-214 nor silencing of EZH2 modulated the expression of LINC01535. Glo cell viability experiments showed that the increase of cell viability caused by LINC01535 overexpression was reversed by miR-214 overexpression or EZH2 silencing ( Figure 5C ). EdU staining experiments showed that the promotion of cell proliferation caused by LINC01535 overexpression was reversed by miR-214 overexpression or EZH2 silencing ( Figure 5D ). Transwell migration assays showed that the increase of cell migration caused by LINC01535 overexpression was reversed by miR-214 overexpression or EZH2 silencing ( Figure 5E ). Transwell invasion assays showed that the increase of cell invasion caused by LINC01535 overexpression was reversed by miR-214 overexpression or EZH2 silencing ( Figure 5F ). Therefore, these findings suggested that activation of the miR-214/EZH2 regulatory loop reverses the roles of LINC01535 on cervical cancer cell growth, migration and invasion.
| LINC01535 promotes cervical cancer growth in vivo via repressing the miR-214/EZH2 regulatory loop
To further investigate the roles of LINC01535/miR-214/EZH2 regula- suppressed HeLa cell apoptosis in vivo, which was also reversed by miR-214 overexpression or EZH2 silencing ( Figure 6D ). Therefore, these findings suggested that LINC01535 promotes cervical cancer growth in vivo via repressing the miR-214/EZH2 regulatory loop.
| LINC01535 is up-regulated and negatively associated with the miR-214/EZH2 regulatory loop in cervical cancer
To 
| D ISCUSS I ON
High throughput sequencings have identified significantly greater number of lncRNAs that mRNAs, with more than 58 000 lncRNAs and only about 21 000 mRNAs. 47 Although some of these lncRNAs have been investigated in human diseases, including cervical cancer, clinical significances of most of these lncRNAs are unclear. [48] [49] [50] [51] [52] In this study, we identified an oncogenic lncRNA LINC01535 in cervical cancer. Our data revealed that LINC01535 is significantly up-regulated in cervical cancer tissues compared with adjacent normal cervical tissues. High expression of LINC01535 is associated with advanced FIGO stage, lymph node metastasis and poor EZH2 as a critical target of miR-214. 34, 44, 54 In the present study, we F I G U R E 5 Activation of the miR-214/EZH2 regulatory axis reverses the roles of LINC01535 on cervical cancer cell growth, migration and invasion. A, LINC01535 and miR-214 expression in LINC01535 and miR-214 concurrently overexpressed, LINC01535 overexpressed and concurrently EZH2 silenced, and control HeLa cells was detected by qRT-PCR. B, EZH2 protein expression in LINC01535 and miR-214 concurrently overexpressed, LINC01535 overexpressed and concurrently EZH2 silenced, and control HeLa cells was detected by wWestern blot. C, Cell viabilities of LINC01535 and miR-214 concurrently overexpressed, LINC01535 overexpressed and concurrently EZH2 silenced, and control HeLa cells were evaluated by Glo cell viability assay. D, Cell growth of LINC01535 and miR-214 concurrently overexpressed, LINC01535 overexpressed and concurrently EZH2 silenced, and control HeLa cells was evaluated by ethynyl deoxyuridine staining. Scale bars, 100 µm. E, Cell migration of LINC01535 and miR-214 concurrently overexpressed, LINC01535 overexpressed and concurrently EZH2 silenced, and control HeLa cells was evaluated by transwell migration assays. Scale bars, 100 µm. F, Cell invasion of LINC01535 and miR-214 concurrently overexpressed, LINC01535 overexpressed and concurrently EZH2 silenced, and control HeLa cells was evaluated by transwell invasion assays. Scale bars, 100 µm. Results are shown as mean ± SD of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, ns, not significant, by one-way ANOVA followed by Dunnett's multiple comparison test further found that enhanced expression of LINC01535 up-regulates the luciferase activity of EZH2 3'UTR and the protein level of EZH2.
Inhibition of LINC01535 down-regulates the luciferase activity of 
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